C150H202F7N29O17S — CID 158218982
N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-5,5-difluoro-5-(6-methoxy-3-pyridinyl)-4-oxopentanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1-fluorocyclopropane-1-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-2-propan-2-ylpyrazole-3-carboxamide (PubChem CID 158218982) has the molecular formula C150H202F7N29O17S and a molecular weight of 2848.50 g/mol. Its IUPAC name is N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-5,5-difluoro-5-(6-methoxy-3-pyridinyl)-4-oxopentanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1-fluorocyclopropane-1-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-2-propan-2-ylpyrazole-3-carboxamide.
| Compound Name | N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-5,5-difluoro-5-(6-methoxy-3-pyridinyl)-4-oxopentanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1-fluorocyclopropane-1-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-2-propan-2-ylpyrazole-3-carboxamide |
|---|---|
| PubChem CID | 158218982 |
| Molecular Formula | C150H202F7N29O17S |
| Molecular Weight | 2848.50 g/mol |
| Exact Mass | 2846.54 |
| IUPAC Name | N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-5,5-difluoro-5-(6-methoxy-3-pyridinyl)-4-oxopentanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]thiadiazole-5-carboxamide;N-[(2R,3S)-3-[4-[[(2S)-2-cycloheptyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanoyl]amino]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-1-fluorocyclopropane-1-carboxamide;2-(cyclopropylmethyl)-N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]pyrazole-3-carboxamide;N-[(2R,3S)-3-[3-fluoro-4-[[(2S)-2-(4-methylcyclohexyl)-4-oxo-4-(2-propan-2-ylpyrazol-3-yl)butanoyl]amino]phenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]-2-propan-2-ylpyrazole-3-carboxamide |
| SMILES | CC1CCC([C@H](CC(=O)c2ccnn2C(C)C)C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3ccnn3C(C)C)C(=O)N3CCN(C)CC3)cc2F)CC1.CC1CCC([C@H](CC(=O)c2ccnn2C(C)C)C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3ccnn3CC3CC3)C(=O)N3CCN(C)CC3)cc2F)CC1.CCn1nccc1C(=O)C[C@H](C(=O)Nc1ccc([C@H](C)[C@@H](NC(=O)C2(F)CC2)C(=O)N2CCN(C)CC2)cc1F)C1CCCCCC1.COc1ccc(C(F)(F)C(=O)C[C@H](C(=O)Nc2ccc([C@H](C)[C@@H](NC(=O)c3cnns3)C(=O)N3CCN(C)CC3)cc2F)C2CCCCCC2)cn1 |
| InChI | InChI=1S/C40H55FN8O4.C39H55FN8O4.C36H44F3N7O5S.C35H48F2N6O4/c1-25(2)49-34(14-17-43-49)36(50)23-31(29-10-6-26(3)7-11-29)38(51)44-33-13-12-30(22-32(33)41)27(4)37(40(53)47-20-18-46(5)19-21-47)45-39(52)35-15-16-42-48(35)24-28-8-9-28;1-24(2)47-33(14-16-41-47)35(49)23-30(28-10-8-26(5)9-11-28)37(50)43-32-13-12-29(22-31(32)40)27(6)36(39(52)46-20-18-45(7)19-21-46)44-38(51)34-15-17-42-48(34)25(3)4;1-22(32(43-34(49)29-21-41-44-52-29)35(50)46-16-14-45(2)15-17-46)24-10-12-28(27(37)18-24)42-33(48)26(23-8-6-4-5-7-9-23)19-30(47)36(38,39)25-11-13-31(51-3)40-20-25;1-4-43-29(13-16-38-43)30(44)22-26(24-9-7-5-6-8-10-24)32(45)39-28-12-11-25(21-27(28)36)23(2)31(40-34(47)35(37)14-15-35)33(46)42-19-17-41(3)18-20-42/h12-17,22,25-29,31,37H,6-11,18-21,23-24H2,1-5H3,(H,44,51)(H,45,52);12-17,22,24-28,30,36H,8-11,18-21,23H2,1-7H3,(H,43,50)(H,44,51);10-13,18,20-23,26,32H,4-9,14-17,19H2,1-3H3,(H,42,48)(H,43,49);11-13,16,21,23-24,26,31H,4-10,14-15,17-20,22H2,1-3H3,(H,39,45)(H,40,47)/t26?,27-,29?,31-,37+;26?,27-,28?,30-,36+;22-,26-,32+;23-,26-,31+/m0000/s1 |
| InChIKey | GCZYTZIHNBQPCO-WJATZEPKSA-N |
| XLogP | 20.99 |
| TPSA | 532.28 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 52 |
| Heavy Atoms | 204 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2848.50 |
| LogP ≤ 5 | 20.99 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 35 |